ROME and MILAN, Jan. 14, 2025 /PRNewswire/ -- Enea TECH and Biomedical Foundation announces a €15 million investment in Tethis S.p.A., a Milan-based company at the forefront of cancer diagnostics.
Tethis is developing innovative solutions for liquid biopsy, a non-invasive blood test that can detect traces of tumor circulating in the blood. The core of Tethis' innovation lies in its integrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results